ADIPOQ and cardiovascular disorder: It was also highlighted that the importance of the possible phenomenon of adiponectin resistance, and the condition of subclinical cardiovascular disease when adiponectin levels may be increased in response to inflammation, which triggers increased expression, synthesis and release—a physiological attempt to limit further endothelial damage [95].